# Three-dimensional super-resolution imaging and tracking of disease and treatment mechanisms of progeria

> **NIH NIH R00** · RICE UNIVERSITY · 2022 · $249,000

## Abstract

Project Summary/Abstract: Methods to obtain quantitative spatiotemporal information about molecular
mechanisms in cells are fundamental for the understanding of why cellular behavior is altered in the progress of
disease. The overall objective of this proposal is to develop a flexible imaging platform for simultaneous multi-
color 3D single-molecule super-resolution (SR) imaging and 3D single-particle tracking of multiple chromosomal
loci with high spatiotemporal resolution throughout entire live mammalian cells, and to use this platform to
determine molecular mechanisms and interactions of the nuclear lamina protein, prelamin A. Mutations in this
protein causes Hutchinson-Gilford Progeria Syndrome (HGPS). Children with HGPS age rapidly, die at a median
age of 13, and have no therapeutic options. Our hypothesis is that drugs inhibiting posttranslational modifications
of mutated prelamin A reduces its toxicity by altering its spatial distribution and molecular interactions.
 The specific aims are to: 1) Develop a strategy to track multiple chromosomal loci in 3D throughout live
mammalian cell nuclei. Combining light sheet illumination, PSF engineering for 3D detection, and nanobody
array labels will result in tracking with tens of nanometers precision over time scales from milliseconds to hours.
2) Extend the imaging platform for multi-color 3D SR imaging and determine the molecular consequences of
inhibiting farnesylation and methylation of prelamin A. Multi-color capability will be added to the imaging platform
and analysis algorithm, and changes in prelamin A distribution and interactions with and without drug treatments
will be measured. 3) Determine how chromatin dynamics are affected by altered (pre)lamin A distribution and
interactions in HGPS and control cells. Correlation between protein distributions and nuclear dynamics will be
mapped by combining the strategies in Aim 1 and 2 and extending the platform for live-cell 3D SR imaging.
 The successful completion of this project will provide an innovative and powerful imaging platform that will
have dramatic impact on biomedical research in the future. The results will be of great significance for children
with HGPS by deducing molecular mechanisms of the syndrome and of a new potential treatment strategy.
Ultimately, this project will also facilitate my long-term career goal of becoming an independent researcher
in academia, pushing the frontiers of cell imaging to address questions in biophysics, biochemistry, and medicine
limited by current techniques. My career development plan includes diverse training topics with a focus on
increasing my skills in biological techniques, which will enable my future independent research. The training will
take place under the guidance of excellent mentors and advisors who have been selected for support and
guidance in all steps of the proposed research. Stanford University offers a complete set of educational resources
including formal coursework and sem...

## Key facts

- **NIH application ID:** 10459333
- **Project number:** 5R00GM134187-03
- **Recipient organization:** RICE UNIVERSITY
- **Principal Investigator:** Anna Karin Eva Gustavsson
- **Activity code:** R00 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $249,000
- **Award type:** 5
- **Project period:** 2019-08-01 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10459333

## Citation

> US National Institutes of Health, RePORTER application 10459333, Three-dimensional super-resolution imaging and tracking of disease and treatment mechanisms of progeria (5R00GM134187-03). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10459333. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*